CCAP Crescent Capital BDC, Inc.
· Nasdaq · SEC CIK 1633336 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-100.4%
TTM EPS YoY-100.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-0.0%
ROA-0.0%
ROIC (approx.)-5.8%
Asset turnover—
Leverage & solvency
Liabilities / assets59.2%
Debt / equity1.39x
Current ratio—
Interest coverage-1.59x
Cash quality & payout
Operating cash flow / net income-212.24x
Accruals ratio-2.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| Operating income | -$98.69M | -$106.78M |
| Interest expense | $57.44M | $62.76M |
| Pretax income | $68.60M | $90.59M |
| Income tax | $6,000 | $155,000 |
| Net income | $34.51M | $73.65M |
| EPS (basic) | 1.81 | 2.40 |
| EPS (diluted) | 1.81 | 2.40 |
| Weighted avg. shares (diluted) | 37.04M | 37.06M |
| Balance sheet | ||
| Cash & equivalents | $5.04M | $10.13M |
| Total assets | $1.62B | $1.66B |
| Long-term debt | $873.76M | $875.84M |
| Total debt | $873.76M | $875.84M |
| Total liabilities | $916.10M | $915.64M |
| Shareholders' equity | $706.04M | $740.64M |
| Net debt | $868.72M | $865.71M |
| Shares outstanding | 36.97M | 37.06M |
| Cash flow statement | ||
| Operating cash flow | $74.72M | $58.91M |
| Financing cash flow | -$82.54M | -$43.47M |
| Dividends paid | $67.81M | $75.23M |
| Share buybacks | $1.33M | — |
Free plan shows the latest 2 periods; Pro shows all 8 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.